title: Treatment of ichthyosiform diseases with topically applied tazarotene: risk of systemic absorption.
authors.forename: Victoria
authors.initials: V
authors.lastname: Nguyen
authors.forename: Bari B
authors.initials: BB
authors.lastname: Cunningham
authors.forename: Lawrence F
authors.initials: LF
authors.lastname: Eichenfield
authors.forename: Alessandra B
authors.initials: AB
authors.lastname: Alió
authors.forename: Robert L
authors.initials: RL
authors.lastname: Buka
mesh_terms: D000287:Administration, Topical; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007057:Ichthyosis / Q000188:drug therapy* / Q000378:metabolism*; D008297:Male; D009539:Nicotinic Acids / Q000008:administration & dosage* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D012307:Risk Factors; D012176:Retinoids
chemical_list: D003879:Dermatologic Agents; D009539:Nicotinic Acids; C086827:tazarotene; D012176:Retinoids